CDKN2A and hepatocellular carcinoma: CDKN2A also played a vital role in regulating the anoikis in hepatocellular carcinoma cells (34) and pancreatic cancer cells (35–38) and hence could serve as an anoikis-related signature gene to predict the prognosis of endometrial carcinoma patients (39).